4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000899243-21-025978
Options or other derivatives
- Director acquired 6,321,460 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-02-24 | Grant or award · Series B convertible preferred stock | +1,500,000 | $2.00 | $3,000,000 | 3,000,000 | I: show line 1 in the form |
| Bolzon Bradley J PhD Director | 2021-02-24 | Grant or award · Series B convertible preferred stock | +2,075,000 | $2.00 | $4,150,000 | 4,150,000 | I: show line 2 in the form |
| Bolzon Bradley J PhD Director | 2021-03-11 | Grant or award · Series C convertible preferred stock | +2,699,328 | $2.96 | $7,999,998 | 2,699,328 | I: show line 3 in the form |
| Bolzon Bradley J PhD Director | 2021-06-23 | Grant or award · Stock Option (Right to Buy) | +47,132 | 47,132 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…